NVS: Novartis AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 190,579.34
Enterprise Value ($M) 209,318.34
Book Value ($M) 59,423.00
Book Value / Share 26.09
Price / Book 3.21
NCAV ($M) -21,120.00
NCAV / Share -9.27
Price / NCAV -9.02

Profitability (mra)
Return on Invested Capital (ROIC) 0.08
Return on Assets (ROA) 0.05
Return on Equity (ROE) 0.10

Liquidity (mrq)
Quick Ratio 1.04
Current Ratio 1.29

Balance Sheet (mrq) ($M)
Current Assets 36,910.00
Assets 117,453.00
Liabilities 58,030.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 51,828.00
Operating Income 12,859.00
Net Income 6,955.00

Cash Flow Statement (mra) ($M)
Cash From Operations 14,236.00
Cash from Investing 1,468.00
Cash from Financing -20,562.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-01 13G/A BlackRock Inc. 5.40 -5.12

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-03-21 160,991 1,755,634 9.17
2023-03-20 245,660 2,546,169 9.65
2023-03-17 224,525 2,248,614 9.99
2023-03-16 181,136 2,119,525 8.55

(click for more detail)

Similar Companies
MYOV – Myovant Sciences Ltd. NUVB – Nuvation Bio Inc
NVO – Novo-Nordisk A/S OGN – Organon & Co.
PBH – Prestige Brands Holdings, Inc.


Financial data and stock pages provided by
Fintel.io